Sage Journals: Discover world-class research

Open access

Research article

First published 2019

Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis

Josep Gamez, María Salvadó, Francesc Carmona [...]

Therapeutic Advances in Neurological Disorders

Open access

Case report

First published 2024

Rescue treatment with add-on efgartigimod in a patient with impending myasthenic crisis: a case report

Zhouao Zhang, Mingjin Yang, Tiancheng Luo [...]

Therapeutic Advances in Neurological Disorders

Open access

Case report

First published 2025

Eculizumab as fast-acting rescue therapy for pembrolizumab-induced impending crisis state of myasthenia gravis: a case report

Ying Huang, Futian Wu, Yihan Xiong [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Case report

First published 2021-8

Late-onset double-seronegative myasthenia gravis syndrome and myasthenic crisis due to nivolumab use for Hodgkin’s lymphoma

Thai Dang, Samir Macwan, Constantin A Dasanu

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2024

Complement inhibition in seropositive generalized myasthenia gravis as rescue therapy in impending and effective treatment in frequently recurring impending myasthenic crisis—a case series

Martina Menacher, Monika Ellssel, Isabelle Kwiedor [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2020

Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis

Munenori Oyama, Kensuke Okada, Masayuki Masuda [...]

Therapeutic Advances in Neurological Disorders

Open access

Case report

First published 2026

Emergency use of eculizumab in impending and manifest myasthenic crisis: a retrospective case series

Ying Huang, Yihan Xiong, Hui Zhan [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Case report

First published 2023-7

Myasthenia Gravis Exacerbation Following Immunization With the BNT162b2 mRNA COVID-19 Vaccine: Report of a Case and Review of the Literature

Marianna Papadopoulou, Maria-Ioanna Stefanou, Lina Palaiodimou [...]

The Neurohospitalist

Open access

Case report

First published 2024

First line treatment with subcutaneous efgartigimod in impending myasthenic crisis: a case report

Isabelle Kwiedor, Martina Menacher, Monika Ellßel [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2021

Effective Early Treatment of AChR Antibody-Positive Myasthenia Gravis with Rituximab;the Experience from a Neuroimmunology Clinic in a Developing Country

Thomas Mathew, Kurian Thomas, Saji K John [...]

Journal of Central Nervous System Disease

Search results